JP2012533065A5 - - Google Patents

Download PDF

Info

Publication number
JP2012533065A5
JP2012533065A5 JP2012519637A JP2012519637A JP2012533065A5 JP 2012533065 A5 JP2012533065 A5 JP 2012533065A5 JP 2012519637 A JP2012519637 A JP 2012519637A JP 2012519637 A JP2012519637 A JP 2012519637A JP 2012533065 A5 JP2012533065 A5 JP 2012533065A5
Authority
JP
Japan
Prior art keywords
saa
diabetes
ratio
subject
subjects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012519637A
Other languages
English (en)
Japanese (ja)
Other versions
JP5748751B2 (ja
JP2012533065A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/040997 external-priority patent/WO2011005717A1/en
Publication of JP2012533065A publication Critical patent/JP2012533065A/ja
Publication of JP2012533065A5 publication Critical patent/JP2012533065A5/ja
Application granted granted Critical
Publication of JP5748751B2 publication Critical patent/JP5748751B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012519637A 2009-07-07 2010-07-02 糖尿病前症及び2型糖尿病における血清アミロイドの表現型比率 Active JP5748751B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22349809P 2009-07-07 2009-07-07
US61/223,498 2009-07-07
PCT/US2010/040997 WO2011005717A1 (en) 2009-07-07 2010-07-02 Phenotypic ratio of serum amyloid in pre- and type 2 diabetes

Publications (3)

Publication Number Publication Date
JP2012533065A JP2012533065A (ja) 2012-12-20
JP2012533065A5 true JP2012533065A5 (https=) 2013-05-30
JP5748751B2 JP5748751B2 (ja) 2015-07-15

Family

ID=43427764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519637A Active JP5748751B2 (ja) 2009-07-07 2010-07-02 糖尿病前症及び2型糖尿病における血清アミロイドの表現型比率

Country Status (5)

Country Link
US (1) US20110008799A1 (https=)
EP (1) EP2451465B1 (https=)
JP (1) JP5748751B2 (https=)
CN (1) CN102481320A (https=)
WO (1) WO2011005717A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160112810A (ko) * 2015-03-20 2016-09-28 삼성전자주식회사 이미지 처리 방법 및 그 전자 장치
CN113080114A (zh) * 2021-04-12 2021-07-09 浙江大学 一种提高鱼类子代成活率的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164818A1 (en) * 1995-05-23 2002-11-07 Gruber Karl F. Mass spectrometric immunoassay analysis of specific proteins and variants present in various biological fluids
JP2005503537A (ja) * 2001-01-17 2005-02-03 エー. タブス,ケモンズ 生体分子分析用ハイ・スループット統合システム
AUPR589801A0 (en) * 2001-06-22 2001-07-19 Autogen Research Pty Ltd Modulation of physiological processes and agents useful for same
US20070087448A1 (en) * 2004-02-16 2007-04-19 Nelsestuen Gary L Biological profiles and methods of use
US8119358B2 (en) * 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
JP2008228646A (ja) * 2007-03-20 2008-10-02 Hokkaido Univ 2型糖尿病診断剤
WO2009006568A1 (en) * 2007-07-03 2009-01-08 Northeastern University Biomarkers for diabetes, obesity, and/or hypertension

Similar Documents

Publication Publication Date Title
Choudhary et al. Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring
Adam et al. Integration of microfluidic channel on electrochemical-based nanobiosensors for monoplex and multiplex analyses: an overview
Blomqvist et al. Salivary cortisol levels and dental anxiety in children with attention deficit hyperactivity disorder
JP6646579B2 (ja) 高アンモニア血症の検出のためのデバイス及びデバイスを使用する方法
WO2010053587A3 (en) Methods of monitoring conditions by sequence analysis
Gerber et al. ASVCP guidelines: quality assurance for portable blood glucose meter (glucometer) use in veterinary medicine
EP2339346A3 (en) Means and methods for predicting diabetes
TW200711660A (en) Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
JP2010537157A5 (https=)
BR112015028573B1 (pt) Kit de diagnóstico para detectar a presença ou quantidade de um ou mais analitos de teste no interior de uma amostra de teste tomada a partir de uma superfície de pele de um mamífero, e, método para detectar a presença ou quantidade de um ou mais analitos de teste
Bresciani et al. Accuracy of capillary blood 3-β-hydroxybutyrate determination for the detection and treatment of canine diabetic ketoacidosis
WO2006073682A3 (en) Diagnostic test
JP2012533066A5 (https=)
Velasco et al. Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity
Zhang et al. A strategy for the development of biomarker tests for PTSD
WO2010045611A3 (en) Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (sle) and other autoimmune diseases
JP2012533065A5 (https=)
Krmar et al. Clinical value of ambulatory blood pressure in pediatric patients after renal transplantation
Paroni et al. Lactulose and mannitol intestinal permeability detected by capillary electrophoresis
EP1376133A4 (en) SCREENING PROCEDURE FOR THE PRÄDIABETIS CONDITION AND SCREENING REAGENT
Chubb et al. The relationship between self-monitoring of blood glucose results and glycated haemoglobin in type 2 diabetes: the fremantle diabetes study
López et al. Relationship between glycated hemoglobin and glucose concentrations in the adult Galician population: selection of optimal glycated hemoglobin cut-off points as a diagnostic tool of diabetes mellitus
Buysschaert et al. Diagnosis of prediabetes and diabetes prevention
Olson In vivo evaluation of BACtrack® Skyn™: a discrete wrist-worn transdermal alcohol monitoring device marketed to the public
KR102745145B1 (ko) 건선 평가용 평가 시스템 및 응용